|
|
||||||||
Clinical Chemistry, Vol 36, 1440-1443, Copyright © 1990 by American Association for Clinical Chemistry
NK Cortas and NW Wakid
Department of Laboratory Medicine, American University Medical Center, Beirut, Lebanon.
Nitrate in serum and urine was assayed by a modification of the cadmium- reduction method; the nitrite produced was determined by diazotization of sulfanilamide and coupling to naphthylethylene diamine. After samples were deproteinized with Somogyi reagent, the nitrate was reduced by Cu-coated Cd in glycine buffer at pH 9.7 (2.5 to 3 g of Cd granules for a 4-mL reaction mixture). The reduction followed pseudo- first-order reaction kinetics, a convenient time interval for assay being 75 to 90 min. Maximum reduction (85%) occurred at about 2 h. Detection limits in urine or serum were 2 to 250 mumol/L. This method does not require the reaction to go to completion, does not require expensive reagents or equipment, and can assay several samples simultaneously. Repeated assays of two serum pools gave CVs of 9.0% and 4.7% for nitrate concentrations of 31.4 and 80.2 mumol/L, respectively (n = 20 each). The mean concentration of nitrate was 1704.0 +/- 1294 (SD) mumol/L (n = 21) in untimed normal urine, 81.8 +/- 50.1 mumol/L in serum of 38 renal dialysis patients, and 51.2 +/- 26.4 mumol/L in serum of 38 controls.
The following articles in journals at HighWire Press have cited this article:
![]() |
H. Yilmaz, E Uz, O Gokalp, N Ozcelik, E Cicek, and M. Ozer Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats Toxicology and Industrial Health, September 1, 2008; 24(8): 519 - 524. [Abstract] [PDF] |
||||
![]() |
G. Kuvandik, M. Duru, A. Nacar, Z. Yonden, R. Helvaci, A. Koc, T. Kozlu, H. Kaya, and S. Sogut Effects of Erdosteine on Acetaminophen-induced Hepatotoxicity in Rats Toxicol Pathol, July 1, 2008; 36(5): 714 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Plant, B. Shand, P. Elder, and R. Scott Adiponectin attenuates endothelial dysfunction induced by oxidised low-density lipoproteins Diabetes and Vascular Disease Research, June 1, 2008; 5(2): 102 - 108. [Abstract] [PDF] |
||||
![]() |
M. Gulec, A. Songur, S. Sahin, O. A Ozen, M. Sarsilmaz, and O. Akyol Antioxidant enzyme activities and lipid peroxidation products in heart tissue of subacute and subchronic formaldehyde-exposed rats: a preliminary study Toxicology and Industrial Health, April 1, 2006; 22(3): 117 - 124. [Abstract] [PDF] |
||||
![]() |
M. Gulec, M. Iraz, H R. Yilmaz, H. Ozyurt, and I. Temel The effects of ginkgo biloba extract on tissue adenosine deaminase, xanthine oxidase, myeloperoxidase, malondialdehyde, and nitric oxide in cisplatin-induced nephrotoxicity Toxicology and Industrial Health, April 1, 2006; 22(3): 125 - 130. [Abstract] [PDF] |
||||
![]() |
B. Altunoluk, H. Soylemez, F. Oguz, E. Turkmen, and E. Fadillioglu An Angiotensin-Converting Enzyme Inhibitor, Zofenopril, Prevents Renal Ischemia/Reperfusion Injury in Rats Ann. Clin. Lab. Sci., January 1, 2006; 36(3): 326 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Cagli, C. Bagci, M. Gulec, B. Cengiz, O. Akyol, I. Sari, S. Cavdar, S. Pence, and H. Dinckan In Vivo Effects of Caffeic Acid Phenethyl Ester on Myocardial Ischemia-Reperfusion Injury and Apoptotic Changes in Rats Ann. Clin. Lab. Sci., October 1, 2005; 35(4): 440 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ozguner, A. Altinbas, M. Ozaydin, A. Dogan, H. Vural, A N. Kisioglu, G. Cesur, and N. G. Yildirim Mobile phone-induced myocardial oxidative stress: protection by a novel antioxidant agent caffeic acid phenethyl ester Toxicology and Industrial Health, August 1, 2005; 21(7-8): 223 - 230. [Abstract] [PDF] |
||||
![]() |
S. Ozgocmen, O. Ardicoglu, H. Erdogan, E. Fadillioglu, and H. Gudul In Vivo Effect of Celecoxib and Tenoxicam on Oxidant/Anti-oxidant Status of Patients with Knee Osteoarthritis Ann. Clin. Lab. Sci., April 1, 2005; 35(2): 137 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iraz, H. Erdogan, B. Ozyurt, F. Ozugurlu, S. Ozgocmen, and E. Fadillioglu Omega-3 Essential Fatty Acid Supplementation and Erythrocyte Oxidant/Antioxidant Status in Rats Ann. Clin. Lab. Sci., April 1, 2005; 35(2): 169 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
H R. Yilmaz, S. Sogut, B. Ozyurt, F. Ozugurlu, S. Sahin, B. Isik, E. Uz, and H. Ozyurt The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester Toxicology and Industrial Health, February 1, 2005; 21(1-2): 67 - 73. [Abstract] [PDF] |
||||
![]() |
A. Terzi, M. Iraz, S. Sahin, A. Ilhan, N. Idiz, and E. Fadillioglu Protective effects of erdosteine on rotenone-induced oxidant injury in liver tissue Toxicology and Industrial Health, July 1, 2004; 20(6-10): 141 - 147. [Abstract] [PDF] |
||||
![]() |
S. Ozgocmen, S. Sogut, E. Fadillioglu, A. Ardicoglu, and O. Ardicoglu Antioxidant status and lipid peroxidation in seminal plasma and spermatozoa of patients with ankylosing spondylitis Rheumatology, June 1, 2003; 42(6): 805 - 807. [Full Text] [PDF] |
||||
![]() |
Y. Totan, O. Cekic, M. Borazan, E. Uz, S. Sogut, and O. Akyol Plasma malondialdehyde and nitric oxide levels in age related macular degeneration Br J Ophthalmol, December 1, 2001; 85(12): 1426 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. May, Z.-C. Qu, L. Xia, and C. E. Cobb Nitrite uptake and metabolism and oxidant stress in human erythrocytes Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1946 - C1954. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Moshage, C. A. Stegeman, and P. L. M. Jansen Determination of Nitrite and Nitrate in Stored Urine Clin. Chem., August 1, 1998; 44(8): 1780 - 1781. [Full Text] [PDF] |
||||
![]() |
J. A. Navarro-Gonzalvez, C. Garcia-Benayas, and J. Arenas Semiautomated Measurement of Nitrate in Biological Fluids Clin. Chem., March 1, 1998; 44(3): 679 - 681. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |